Dr. Su is a breast cancer surgeon with focus on breast cancer minimal assess surgery and immunotherapy. He is Deputy Leader of Expert Working Group of Breast Surgeons, Chinese college of Surgeons, Chinese Medical Doctor Association and Chairman-Elected of the Breast Cancer Committee, Guangdong Provincial Anticancer Association. He has pioneered several robotic/endoscopic-assisted breast cancer surgical techniques and is leading several international multicenter prospective randomized clinical trials of breast cancer minimal assess surgery.  He reveals a number of previous unappreciated immunotherapy targets, such as circRNA-encoded tumor neoantigens, and is leading several immune cell therapy.